This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
Current Hematologic Malignancy Reports Open Access 01 June 2023
-
Genomic alterations in a cohort of pediatric acute myeloid leukemia patients at two cancer centers in Colombia
International Journal of Hematology Open Access 24 October 2022
-
Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells
Blood Cancer Journal Open Access 25 August 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Frohling S, Scholl C, Gilliland DG, Levine RL . Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol 2005; 23: 6285–6295.
Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254–266.
Leroy H, Roumier C, Huyghe P, Biggio V, Fenaux P, Preudhomme C . CEBPA point mutations in hematological malignancies. Leukemia 2005; 19: 329–334.
Chou WC, Tang JL, Lin LI, Yao M, Tsay W, Chen CY et al. Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution. Cancer Res 2006; 66: 3310–3316.
Lin LI, Chen CY, Lin DT, Tsay W, Tang JL, Yeh YC et al. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells. Clin Cancer Res 2005; 11: 1372–1379.
Boissel N, Renneville A, Biggio V, Philippe N, Thomas X, Cayuela JM et al. Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype. Blood 2005; 106: 3618–3620.
Tiesmeier J, Czwalinna A, Muller-Tidow C, Krauter J, Serve H, Heil G et al. Evidence for allelic evolution of C/EBPalpha mutations in acute myeloid leukaemia. Br J Haematol 2003; 123: 413–419.
Suzuki T, Kiyoi H, Ozeki K, Tomita A, Yamaji S, Suzuki R et al. Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia. Blood 2005; 106: 2854–2861.
Smith LL, Pearce D, Smith ML, Jenner M, Lister TA, Bonnet D et al. Development of a quantitative real-time polymerase chain reaction method for monitoring CEBPA mutations in normal karyotype acute myeloid leukaemia. Br J Haematol 2006; 133: 103–105.
Gorello P, Cazzaniga G, Alberti F, Dell'oro MG, Gottardi E, Specchia G et al. Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations. Leukemia 2006; 20: 1103–1108.
Acknowledgements
This study was supported in part by Grant NTUH 94-S68 from National Taiwan University Hospital, Taiwan, and Grant NSC94-2320-B002-084 from National Science Council, Taiwan.
Author information
Authors and Affiliations
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Rights and permissions
About this article
Cite this article
Lin, LI., Lin, TC., Chou, WC. et al. A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias. Leukemia 20, 1899–1903 (2006). https://doi.org/10.1038/sj.leu.2404331
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404331
This article is cited by
-
Genomic alterations in a cohort of pediatric acute myeloid leukemia patients at two cancer centers in Colombia
International Journal of Hematology (2023)
-
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
Current Hematologic Malignancy Reports (2023)
-
Improved Variant Detection in Clinical Myeloid NGS Testing by Supplementing a Commercial Myeloid NGS Assay with Custom or Extended Data Filtering and Accessory Fragment Analysis
Molecular Diagnosis & Therapy (2021)
-
Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells
Blood Cancer Journal (2020)
-
NPM1, FLT3 and CEBPA mutations in pediatric patients with AML from Argentina: incidence and prognostic value
International Journal of Hematology (2016)